Key result
CeO2 nanoparticles exacerbate myocardial ischemia-reperfusion injury and vascular dysfunction via mast cell activation in mice.
Answers are grounded in this paper and cite their sources.
Cerium oxide (CeO₂) represents an important nanomaterial with wide ranging applications. However, little is known regarding how CeO₂ exposure may influence pulmonary or systemic inflammation. Furthermore, how mast cells would influence inflammatory responses to a nanoparticle exposure is unknown. We thus compared pulmonary and cardiovascular responses between C57BL/6 and B6.Cg-Kit(W-sh) mast cell deficient mice following CeO₂ nanoparticle instillation. C57BL/6 mice instilled with CeO₂ exhibited mild pulmonary inflammation. However, B6.Cg-Kit(W-sh) mice did not display a similar degree of inflammation following CeO₂ instillation. Moreover, C57BL/6 mice instilled with CeO₂ exhibited altered aortic vascular responses to adenosine and an increase in myocardial ischemia/reperfusion injury which was absent in B6.Cg-Kit(W-sh) mice. In vitro CeO₂ exposure resulted in increased production of PGD₂, TNF-α, IL-6 and osteopontin by cultured mast cells. These findings demonstrate that CeO₂ nanoparticles activate mast cells contributing to pulmonary inflammation, impairment of vascular relaxation and exacerbation of myocardial ischemia/reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Wingard et al. (2010) studied Nanoparticle-induced pulmonary inflammation and ischemia/reperfusion injury. Cerium oxide (CeO2) nanoparticle instillation vs. Mast cell deficient mice (B6.Cg-Kit(W-sh)) vs wild-type mice (C57BL/6) was evaluated on Pulmonary inflammation, aortic vascular response, and myocardial ischemia/reperfusion injury. CeO2 nanoparticles activate mast cells, contributing to pulmonary inflammation, impaired vascular relaxation, and exacerbated myocardial ischemia/reperfusion injury in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: